98 related articles for article (PubMed ID: 1577978)
1. AUA1: new immunocytochemical marker for detecting epithelial cells in body cavity fluids.
Kocjan G; Sweeney E; Miller KD; Bobrow L
J Clin Pathol; 1992 Apr; 45(4):358-9. PubMed ID: 1577978
[TBL] [Abstract][Full Text] [Related]
2. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
[TBL] [Abstract][Full Text] [Related]
3. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture.
Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG
Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412
[TBL] [Abstract][Full Text] [Related]
4. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.
Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E
J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290
[TBL] [Abstract][Full Text] [Related]
5. Comparison of monoclonal antibodies AUA1 and BER EP4 with anti-CEA for detecting carcinoma cells in serous effusions and distinguishing them from mesothelial cells.
Robinson RJ; Royston D
Cytopathology; 1993; 4(5):267-71. PubMed ID: 8274664
[TBL] [Abstract][Full Text] [Related]
6. Role of immunoperoxidase staining in serous effusions.
Sarker AB; Hoshida Y; Nose S
Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of sialosyl-Tn in discriminating carcinomatous cells from benign mesothelium in body cavity effusions.
Zimmerman RL; Fogt F; Bibbo M
Acta Cytol; 1999; 43(6):1079-84. PubMed ID: 10578981
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical detection of XIAP in body cavity effusions and washes.
Wu M; Yuan S; Szporn AH; Gan L; Shtilbans V; Burstein DE
Mod Pathol; 2005 Dec; 18(12):1618-22. PubMed ID: 16118627
[TBL] [Abstract][Full Text] [Related]
10. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
11. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic characteristics of the CA-50 and CA 72-4 tumor markers in body fluids. Use in the diagnosis of malignant effusions].
Lemberger J; Libman E; Lászlo-Klein M; Skenderović S; Novak A
Med Pregl; 1991; 44(3-4):126-9. PubMed ID: 1921859
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of the immunocytochemical study of body fluids.
Li CY; Ziesmer SC; Wong YC; Yam LT
Acta Cytol; 1989; 33(5):667-73. PubMed ID: 2675517
[TBL] [Abstract][Full Text] [Related]
14. Tumour associated antigens in diagnosis of serous effusions.
Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
16. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
Ghosh AK; Mason DY; Spriggs AI
J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
Singer S; Boddington MM; Hudson EA
J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
[TBL] [Abstract][Full Text] [Related]
19. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
Loy TS; Diaz-Arias AA; Bickel JT
Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine: new tumor marker in pleural fluid.
Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
